In this article, we will look at oversold names that offer double-digit ROE growth for investors across sectors. On April 3, markets were affected by political concerns once more after President Trump indicated that the war with Iran would continue for some weeks, sending oil prices soaring and affecting the stocks. The Dow Jones fell by 61 points or 0.13%, while the S&P500 and Nasdaq had small increases of 0.11% and 0.18%, respectively.
During the trading hours, markets reacted favorably to the news reported by the Iranian state-run media that the country is engaged with Oman to establish protocols for monitoring vessels transiting through the Strait of Hormuz. According to Todd Schoenberger, Chief Investment Officer at CrossCheck Management, this carries importance not just because of the oil but also helium. He emphasized the importance of helium given its significance in the production of semiconductors, since there is no alternative to it. Schoenberger stated:
Currently in our own domestic economy, helium is more valuable than foreign oil because it’s used to cool the processing of semiconductors and there is no substitute for it.
The bottom line for investors in such an environment is evident. Geopolitical events will continue to fuel market fluctuations, and investors must play their cards accordingly. The coming few days are likely to be volatile for the market as it processes numerous events, with oil prices and chip shortages remaining key issues.
With that background, let’s explore our 7 Oversold Stocks to Buy With Double-Digit ROE Growth.
Copyright: welcomia / 123RF Stock Photo
Our Methodology
To identify relevant stocks for this article, we conducted a sector-agnostic screening of U.S.-listed companies with market capitalizations above $2 billion, an RSI indicator below 30, and forward ROE growth greater than 10%.
Also, we only shortlisted stocks with at least 65% upside potential, according to analyst consensus as of the April 10 close. Finally, we selected 7 stocks with the highest upside and ranked them in ascending order.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
7. Boston Scientific Corp. (NYSE:BSX)
Boston Scientific Corp. (NYSE:BSX) is one of the 7 oversold stocks to buy with double-digit ROE growth.
On April 7, Joanne Wuensch from Citi reduced the price target on Boston Scientific Corp. (NYSE:BSX) from $98 to $87 while maintaining a Buy rating on the stock. This implies an adjusted upside potential of more than 40% despite the downward revision in price target.
Joanne noted that the medical technology segment is currently facing several compressions because of the uncertainties involved. Consequently, as part of the first quarter earnings preview, the firm revised its estimates across the group.
On March 30, Boston Scientific Corp. (NYSE:BSX) and Penumbra Inc. (NYSE:PEN) announced an updated regulatory timeline concerning their proposed corporate merger. Previously, both organizations submitted initial notification documents to both the FTC and the DOJ under the HSR Act on February 13.
The intervention prolongs the mandatory waiting period until 30 days after the organizations substantially satisfy all compliance demands, unless the parties voluntarily extend the timeline or regulators finish the evaluation early. Executive leadership expects to respond promptly while actively cooperating with federal authorities.
Boston Scientific Corp. (NYSE:BSX) specializes in medical devices for interventional specialties such as cardiovascular, endo-surgery, and neuro-modulation. The company operates through MedSurg and Cardiovascular segments, and offers a range of devices, including biliary stent systems, electrocautery enhanced delivery systems, direct visualization systems, and single-use duodeno-scopes.
6. Blue Owl Capital Inc. (NYSE:OWL)
Blue Owl Capital Inc. (NYSE:OWL) is one of the 7 oversold stocks to buy with double-digit ROE growth.
On April 7, Piper Sandler reduced the price target on Blue Owl Capital Inc. (NYSE:OWL) from $15 to $12.50 while maintaining an Overweight rating on the stock. The firm pointed out that the asset management segment experienced a tough beginning in 2026 compared to both the market and the finance industry.
This stems from increased pressure on private credit, redemption from direct lending wealth products, weak equities, and poor capital market visibility due to uncertainty and the Iran situation. While these macroeconomic factors will not vanish immediately, Piper thinks that catastrophic downsides are fully priced in much of its coverage universe.
On April 2, Blue Owl Capital Inc. (NYSE:OWL) announced increased requests for shareholder redemptions in two private credit portfolios in the first quarter. Withdrawal queries totaling 21.9% of outstanding shares were received by the firm’s flagship OCIC fund, which manages about $36 billion.
Concurrently, demand for withdrawals from the smaller technology-focused portfolio has risen to 40.7%. According to Jefferies, software enterprises account for approximately 20% of the overall portfolio of business development companies. What’s causing this withdrawal activity is the market’s increased anxiety over AI’s ability to upend the software sector. Due to the mandated 5% withdrawal limitations and robust gross inflows, there were relatively minor net outflows at the current level.
Blue Owl Capital Inc. (NYSE:OWL) is an alternative asset manager that offers capital solutions to mid-market companies. With an emphasis on credit, real assets, and GP strategic capital, it provides private financing, direct lending, opportunistic lending, equity financing, and leasing solutions. It is well-reputed for delivering a differentiated route to private markets and secular growth trends.
While we acknowledge the potential of OWL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than OWL and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Oversold Stocks to Buy With Double-Digit ROE Growth.
Disclosure: None. Follow Insider Monkey on Google News.
